Regenxbio Inc. delivered a strong quarter, driven by milestone revenue, with GAAP EPS of $0.43 and r

Wall Street analysts upgraded PTGX, LECO, and JHX. See analyst ratings and price targets for these s

Wall Street analysts changed outlook on top names. For rating changes, check our analyst ratings pag

Top Wall Street analysts changed outlook on top names. For all changes & stock ratings, see anal

REGENXBIO NASDAQ: RGNX reported second-quarter 2026 progress across its late-stage gene-therapy pipe

REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call Transcript

Regenxbio (RGNX) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Es

RGX-202 BLA submission for Duchenne muscular dystrophy on track for Q3 2026 initiation, with potenti

ROCKVILLE, Md., Aug. 3, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it w

ABR, ARDX and RGNX have been added to the Zacks Rank #5 (Strong Sell) List on July 23, 2026.

NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin

REGENXBIO Inc. (NASDAQ:RGNX) on Saturday shared long-term clinical trial findings for its experiment

REGENXBIO announced positive long-term sura-vec trial data for wet AMD and diabetic retinopathy, alo

REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinop

One-time gene therapy treatment with sura-vec demonstrated long-term efficacy at similar doses to th

Nasdaq falls over 200 points, Dow down 0.28%, S&P 500 drops 0.51%. Energy shares up 1.4%, commun

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s

U.S. stock futures lower, Nasdaq 100 down 2%. Intuitive Surgical shares dip 11.3% after Q2 earnings

NFLX: 10% | Netflix shares are trading lower after the company reported worse-than-expected Q2 sales

ROCKVILLE, Md., July 17, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the pric

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

ROCKVILLE, Md., July 16, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

New long-term data from diabetic retinopathy and wet AMD programs to be presented at American Societ

REGENXBIO upgraded to 'Strong Buy' on FDA's course reversal for rare disease therapies, notably impa

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator

RGNX shares jump after FDA alignment on next steps for Navsunli, paving the way for a planned MPS II

Regenxbio Inc. (NASDAQ:RGNX) on Monday said it aligned with the Food and Drug Administration (FDA) r

FDA confirmed no additional studies required, existing longer-term data from the CAMPSIITE ® study w

The ​U.S. Food ‌and Drug ​Administration ​will reverse ⁠its ​earlier ​rejection of a ​rare-disease ​

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer